Search Results
Results found for "assay development"
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Moving forward, implementing and developing assay technologies that strategically operate using unmodified Why 90% of clinical drug development fails and how to improve it? How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment. Clinical development times for innovative drugs. Drug discovery and development: Role of basic biological research.
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Hello GPCR friends👋, Stay informed with the latest developments in GPCR research and industry news! GPCRs in drug discovery: challenges & solutions (June 19 - 23, 2023) Training School on “Cell-based assays
- Adhesion GPCR Consortium Newsletter - May 2024
understand how aGPCR works but might also provide a guide to how pharmacological approaches will be developed among the aGPCR community, added to the fact that this will all take place for the first time in a developing all 33 aGPCRs in a suite of transcriptional reporter, G protein activation and B-arrestin recruitment assays
- Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage...
Furthermore, ROCK activity assays were performed to evaluate the ability of various physiological GPCR
- Exploring the Breakthroughs in GPCR Research
GPCR Events, Meetings, and Webinars September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays
- 📰 GPCR Weekly News, June 24 to 30, 2024
GPCR Events, Meetings, and Webinars September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays
- 📰 GPCR Weekly News, August 21 to 27, 2023
Discovery Engine and Pipeline of Small Molecule Therapeutics Reproducibility of Tanso Biosciences' GPCR Assay
- 📰 GPCR Weekly News, September 11 to 17, 2023
Drug Shows Potential for Treatment of Cannabis Use Disorder Reproducibility of Tanso Biosciences' GPCR Assay
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
Example: Your platform team is building a modular assay framework.
- 📰 GPCR Weekly News, February 19 to 25, 2024
lipid second messenger signaling Methods & Updates in GPCR Research A bioluminescent and homogeneous assay
- Overview of adhesion GPCRs self-activation
Through cell-based assays and Cryo-EM of high quality, it was possible to know that ADGRL3 can activate
- Decoding β-Arrestins: from Structure to function
transfer (FRET), bioluminescence resonance energy transfer (BRET), and multi-color fluorescence microscopy assays
- Understanding Orthosteric Binding: The Key to Drug Action
Understanding this process is crucial for anyone interested in drug development and action. This foundational knowledge guides researchers in the development of new therapeutics. Implications for Drug Development As drug developers, understanding these nuances can significantly impact This understanding can enhance your appreciation for drug development and therapeutic action.
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
Maria Majellaro Now, she leads a team of talented chemists at Celtarys, developing fluorescent ligands GPCR on the company page . _______________ Keyword Cloud: GPCR scientist network , career development
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
And if your development plan was designed to persuade , not to withstand pressure , then you are not to demonstrate confidence, the FDA is systematically looking for structural weak points across your development your plan shows signs of future collapse . 👉 When they spot a mismatch between your data and your development Reverse Engineering Your Path to FDA Approval Most biotech development plans are built forward : start This is the principle of strategic reverse engineering . 👉 It means designing your development path
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
training planted the seeds for what would later become Blue Therapeutics, a startup he co-founded to develop behavior computationally predictable, Ajay and his team are working to reduce the time and cost of developing early career redirection to startup setbacks, each step has added new layers to his thinking about drug development He also underscores the value of developing cross-functional skills — including communication, strategy
- Building Backwards: Why Top-Down Models Could Revolutionize Pain Research
This approach reflects his focus on developing models that behave like patients before molecular exploration "I'm particularly interested in model development... seeing if we can bring preclinical models much closer
- Pharmacologic Models
Probability Models This is practical drug development expertise from Terry’s 40+ years of experience
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
The development of molecular tools to study GPCR trafficking in real-time opens new avenues for understanding opioid crisis continues to challenge public health, insights gained from this research could inform the development beyond basic science ; understanding the role of DNAJC13 in GPCR trafficking could profoundly affect the development
- Do You Believe AI Could Accelerate Drug Discovery?
The advent of AlphaFold2 (AF2) has brought AI applications in drug development to unprecedented heights with atomic-level accuracy and remarkable scalability, providing crucial structural insights for drug development Despite its transformative potential, AI in drug development faces several challenges. Looking ahead, AI offers significant advantages in drug development, such as the ability to tackle complex
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
Allosteric modulators offer a promising approach for developing drugs that enhance or inhibit receptor important residues are within the ligand-binding pocket, resulting in a significant opportunity for developing Understanding the evolutionary conservation of these residues can lead to the development of drugs that determinants of ligand efficacy and potency in GPCR signalling, this research provides a foundation for the development
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
Fortunately, several techniques and methodologies have been developed to support this process. receptors can provide valuable insights for structure-activity relationship (SAR) studies, informing the development To overcome these challenges, future directions include developing high-throughput techniques, better For instance, Heydenreich et al. (2023) developed a data science framework that combined mutagenesis Flipping the GPCR switch: Structure-based development of selective cannabinoid receptor 2 inverse agonists
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
biased signaling, and allosteric modulation, this session lays bare the science that’s reshaping how we develop
- Ever Wondered How Drugs Are Discovered?
the language, logic, and big-picture view that underpins all future learning in pharmacology and drug development
- 📰 GPCR Weekly News, June 10 to 16, 2024
Stay informed with the most recent developments in GPCR research and industry news. hiPSC-cardiomyocytes to GPCR and ion channel targeting compounds: A microphysiological system for cardiac drug development Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
a place for teams to get tailored scientific and strategic guidance that helps bridge discovery and development Our access program for researchers in developing countries continues as well: eligible scientists can GPCR University course reserves five complimentary seats for students from developing countries — no
- 📰 GPCR Weekly News, February 6 to 12, 2023
Development and Characterization of a Highly Selective Turn-On Fluorescent Ligand for β3-Adrenergic Receptor Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1 IPO Raises $161M for GPCR-Based Drug Developer Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. GPCR Jobs Director, Business Development & Strategy CADD and Informatics Head or Team Lead (depending PhD student at Department of Drug Design and Pharmacology Software / database development postdoc at
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Predicting and Overcoming Drug Resistance A significant challenge in drug development, particularly in designed to target multiple sites or pathways simultaneously, reducing the likelihood of resistance development This can guide the development of more personalised therapies tailored to the genetic makeup of individual Another promising development is the application of DMS to a wider array of biological systems, including
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
: Explore a selection of high-level job openings in high-throughput screening, research, biologics development compounds that might be missed by traditional screening methods, gaining a first-mover advantage in developing Gain a deeper understanding of the pharmacological underpinnings of opioid overdose, informing the development
- From DNA day to GPCR genomics
This breakthrough also paved the way for the development of genomics, a field of study that examines genomics and GPCR research sparked a new era of a comprehensive understanding of GPCR biology, the development bioinformatics analysis, have facilitated drug discovery and design targeting GPCRs, leading to the development pharmacology, bioinformatics, and clinical research has opened new avenues for exploring GPCR biology, developing



















